Advancements are continually being made in the rapidly evolving field of cancer diagnosis to improve detection and treatment methods. One such breakthrough is the circulating tumor cell (CTC) count test, which offers a noninvasive and convenient way to analyze blood samples for cancer cells. These tests can revolutionize diagnosing cancer, providing early detection and personalized treatment options.
What Are Circulating Tumor Cells (CTCs)?
Circulating Tumor Cells (CTCs) are cancer cells detached from a primary tumor and entering the bloodstream. These cells can travel through the circulatory system to other parts of the body, potentially causing metastasis and the spread of cancer. CTCs are extremely rare and difficult to detect, but their presence in the bloodstream can provide valuable information about the nature and progression of the disease.
CTC count tests involve isolating and analyzing these circulating tumor cells from a patient’s blood sample. By capturing and counting CTCs, healthcare professionals …